Cargando…

Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the Art

Hepatocellular carcinoma (HCC) is a malignancy that requires multidisciplinary evaluation to develop individualized and tailored treatment concepts. While liver resection and transplantation represent the mainstay of curative treatment in patients with early-stage HCC, disease recurrence remains an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laschtowitz, Alena, Roderburg, Christoph, Tacke, Frank, Mohr, Raphael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922501/ https://www.ncbi.nlm.nih.gov/pubmed/36789252 http://dx.doi.org/10.2147/JHC.S347944

Ejemplares similares

Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression
por: Laschtowitz, Alena, et al.
Publicado: (2023)

The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma—State of the Art and Future Perspectives
por: Eschrich, Johannes, et al.
Publicado: (2023)

In Situ Vaccination as a Strategy to Modulate the Immune Microenvironment of Hepatocellular Carcinoma
por: Lurje, Isabella, et al.
Publicado: (2021)

Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies
por: Roderburg, Christoph, et al.
Publicado: (2020)

The role of the innate immune system in the development and treatment of hepatocellular carcinoma
por: Roderburg, Christoph, et al.
Publicado: (2020)

Pulmonary Complications in Patients with Liver Cirrhosis
por: Benz, Fabian, et al.
Publicado: (2020)

Atezolizumab and bevacizumab-induced encephalitis in advanced hepatocellular carcinoma: Case report and literature review
por: Özdirik, Burcin, et al.
Publicado: (2021)

Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma
por: Mohr, Raphael, et al.
Publicado: (2021)

The APAC Score: A Novel and Highly Performant Serological Tool for Early Diagnosis of Hepatocellular Carcinoma in Patients with Liver Cirrhosis
por: Lambrecht, Joeri, et al.
Publicado: (2021)

Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
por: Costa, Frederico, et al.
Publicado: (2023)

In Vivo Models for Cholangiocarcinoma—What Can We Learn for Human Disease?
por: Mohr, Raphael, et al.
Publicado: (2020)

Current state and challenges of emerging biomarkers for immunotherapy in hepatocellular carcinoma (Review)
por: Cheng, Mo, et al.
Publicado: (2023)

Immunotherapy for hepatocellular carcinoma: Current and future
por: Johnston, Michael P, et al.
Publicado: (2019)

Mouse models of hepatocarcinogenesis: What can we learn for the prevention of human hepatocellular carcinoma?
por: Vucur, Mihael, et al.
Publicado: (2010)

Hepatocellular carcinoma: State of the art diagnostic imaging
por: Criss, Cody, et al.
Publicado: (2023)

Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
por: Datfar, Toofan, et al.
Publicado: (2021)

Immunotherapy for hepatocellular carcinoma: current status and future perspectives
por: Okusaka, Takuji, et al.
Publicado: (2018)

Hepatocellular Carcinoma and Liver Transplantation: State of the Art
por: Mancuso, Andrea, et al.
Publicado: (2014)

State of The Art in Magnetic Resonance Imaging of Hepatocellular Carcinoma
por: Horvat, Natally, et al.
Publicado: (2018)

State of the Art in Artificial Intelligence and Radiomics in Hepatocellular Carcinoma
por: Castaldo, Anna, et al.
Publicado: (2021)

Radiomics in hepatocellular carcinoma: A state-of-the-art review
por: Yao, Shan, et al.
Publicado: (2021)

Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
por: Xie, Yingjun, et al.
Publicado: (2018)

Current Landscape and Future Directions of Biomarkers for Immunotherapy in Hepatocellular Carcinoma
por: Gok Yavuz, Betul, et al.
Publicado: (2021)

Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art
por: Lebastchi, Amir H., et al.
Publicado: (2012)

Hepatocellular Carcinoma: State of the Art Imaging and Recent Advances
por: Navin, Patrick J., et al.
Publicado: (2019)

Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma
por: Peiseler, Moritz, et al.
Publicado: (2021)

Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review
por: Candita, Gianvito, et al.
Publicado: (2023)

Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art
por: Facciorusso, Antonio
Publicado: (2018)

Current frontline approaches in the management of hepatocellular carcinoma: the evolving role of immunotherapy
por: Brar, Gagandeep, et al.
Publicado: (2018)

Immunotherapy for Hepatocellular Carcinoma: Current Limits and Prospects
por: Zhong, Cheng, et al.
Publicado: (2021)

The Role of Adipokines as Circulating Biomarkers in Critical Illness and Sepsis
por: Loosen, Sven H., et al.
Publicado: (2019)

From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis
por: Mohr, Raphael, et al.
Publicado: (2021)

Immunotherapy for Esophageal Cancer: State-of-the Art in 2021
por: Teixeira Farinha, Hugo, et al.
Publicado: (2022)

The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma
por: Montella, Liliana, et al.
Publicado: (2021)

Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State-of-the-Art Review
por: Reiter, Florian P., et al.
Publicado: (2022)

Advances in Immunotherapy for Hepatocellular Carcinoma
por: Hagiwara, Satoru, et al.
Publicado: (2023)

Neoadjuvant Immunotherapy for Hepatocellular Carcinoma
por: Marron, Thomas U, et al.
Publicado: (2022)

Treatment Strategies for Hepatocellular Carcinoma—A Multidisciplinary Approach
por: Lurje, Isabella, et al.
Publicado: (2019)

Pharmacogenomics: Current State-of-the-Art
por: Carr, Daniel F., et al.
Publicado: (2014)

The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors
por: Geisler, Lukas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j95i9ilpms5dicd3r6fkqca55l